BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
100 hedge funds and large institutions have $150M invested in Bellicum Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+4
Holders Change %
+4.17%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
31
Reduced
28
Closed
8
Calls
$942K
Puts
$314K
Net Calls
+$628K
Net Calls Change
+$1.32M
Top Buyers
| 1 |
BlackRock
New York
|
+$1.96M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.89M |
| 3 |
JPMorgan Chase & Co
New York
|
+$1.85M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$842K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$616K |
Top Sellers
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$8.72M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.09M |
| 3 |
Millennium Management
New York
|
-$787K |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$664K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$645K |
